JP2023546384A5 - - Google Patents
Info
- Publication number
- JP2023546384A5 JP2023546384A5 JP2023521845A JP2023521845A JP2023546384A5 JP 2023546384 A5 JP2023546384 A5 JP 2023546384A5 JP 2023521845 A JP2023521845 A JP 2023521845A JP 2023521845 A JP2023521845 A JP 2023521845A JP 2023546384 A5 JP2023546384 A5 JP 2023546384A5
- Authority
- JP
- Japan
- Prior art keywords
- virus
- pharmaceutical composition
- respiratory
- composition according
- cov
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| KR10-2020-0134344 | 2020-10-16 | ||
| KR20200134344 | 2020-10-16 | ||
| KR20210028215 | 2021-03-03 | ||
| KR10-2021-0028215 | 2021-03-03 | ||
| PCT/KR2021/014485 WO2022080991A1 (ko) | 2020-10-16 | 2021-10-18 | 글루카곤, glp-1 및 gip 수용체 모두에 활성을 갖는 삼중 활성체의 호흡기 감염 질환의 후유증의 치료 용도 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2023546384A JP2023546384A (ja) | 2023-11-02 |
| JP2023546384A5 true JP2023546384A5 (https=) | 2024-10-29 |
Family
ID=81207490
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023521845A Pending JP2023546384A (ja) | 2020-10-16 | 2021-10-18 | グルカゴン、ｇｌｐ－１及びｇｉｐ受容体の全てに対して活性を有する三重活性体の呼吸器感染疾患の後遺症の治療用途 |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US20230390362A1 (https=) |
| EP (1) | EP4230220A4 (https=) |
| JP (1) | JP2023546384A (https=) |
| KR (1) | KR20220050824A (https=) |
| TW (1) | TW202233226A (https=) |
| WO (1) | WO2022080991A1 (https=) |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6096871A (en) | 1995-04-14 | 2000-08-01 | Genentech, Inc. | Polypeptides altered to contain an epitope from the Fc region of an IgG molecule for increased half-life |
| JP4046354B2 (ja) | 1996-03-18 | 2008-02-13 | ボード オブ リージェンツ，ザ ユニバーシティ オブ テキサス システム | 増大した半減期を有する免疫グロブリン様ドメイン |
| TW201625669A (zh) * | 2014-04-07 | 2016-07-16 | 賽諾菲公司 | 衍生自艾塞那肽－４（Ｅｘｅｎｄｉｎ－４）之肽類雙重ＧＬＰ－１／升糖素受體促效劑 |
| SG11201805586SA (en) | 2015-12-31 | 2018-07-30 | Hanmi Pharmaceutical Co Ltd | Triple glucagon/glp-1/gip receptor agonist |
| WO2020071865A1 (ko) * | 2018-10-04 | 2020-04-09 | 한미약품 주식회사 | 글루카곤 및 이를 포함하는 조합물의 치료학적 용도 |
| MX2022008646A (es) * | 2020-01-13 | 2022-08-10 | Hanmi Pharm Ind Co Ltd | Uso terapeutico de un conjugado de accion prolongada de un triple agonista que tiene actividad en todos los receptores de glucagon/glp-1/gip para enfermedades pulmonares. |
-
2021
- 2021-10-18 TW TW110138562A patent/TW202233226A/zh unknown
- 2021-10-18 US US18/031,958 patent/US20230390362A1/en active Pending
- 2021-10-18 EP EP21880637.0A patent/EP4230220A4/en active Pending
- 2021-10-18 KR KR1020210138700A patent/KR20220050824A/ko active Pending
- 2021-10-18 JP JP2023521845A patent/JP2023546384A/ja active Pending
- 2021-10-18 WO PCT/KR2021/014485 patent/WO2022080991A1/ko not_active Ceased
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2005523946A5 (https=) | ||
| JP2023520323A5 (https=) | ||
| JP2024504225A5 (https=) | ||
| CN112386595A (zh) | 一种治疗呼吸系统病毒性感染的药物组合物 | |
| JP2024178420A5 (https=) | ||
| JP2023524081A (ja) | ヒアルロナンコンジュゲートの使用 | |
| CN103200955A (zh) | 包含肽和病毒神经氨酸酶抑制剂的组合物 | |
| KR20210091032A (ko) | 글루카곤, glp-1 및 gip 수용체 모두에 활성을 갖는 삼중 활성체의 지속형 결합체의 폐질환의 치료 용도 | |
| JP2023546384A5 (https=) | ||
| US20120100155A1 (en) | Pharmaceutical agent | |
| JP2023532170A5 (https=) | ||
| CN114246937B (zh) | 白细胞介素37与干扰素联用在治疗病毒感染中的应用 | |
| EP2138513A1 (en) | Pharmaceutical compositions of antibodies for diseases caused by viruses | |
| US5900235A (en) | Interleukin-8 as an antiviral and antitumor agent | |
| JP2003531822A (ja) | 自己免疫疾患を治療するためのｔｈ−１免疫反応誘導サイトカインの拮抗薬 | |
| JP2024542777A5 (https=) | ||
| CN118845782A (zh) | Zinc62678696在防治肺炎中的应用 | |
| JP2023534091A (ja) | 炎症の治療における使用のための３－アザビシクロ［３．２．１］オクタンカルボン酸およびその誘導体 | |
| AU633558B2 (en) | Interferon for the use in the prevention or treatment of swine pneumonia or related bacterial diseases | |
| JPH0341030A (ja) | 抗ウイルス剤 | |
| Li | Advances in the study of cytokine storm mechanisms in pneumonia: An example of IL-6 and IL-33 | |
| CN118490680B (zh) | 瑞香素在制备治疗病毒性肺炎的药物中的应用 | |
| WO2004112795A1 (en) | Ltb4 compositions for treating tract infections | |
| JP2024511660A (ja) | ポストｃｏｖｉｄ－１９を治療する方法における使用のためのエズリンペプチド１ | |
| JPH09509409A (ja) | 経口型のムラミルペプチド・ジエステル |